
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Reversal of Opioid‐Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone
Mark J. Ellison, Emily Hutton, Lynn R. Webster, et al.
The Journal of Clinical Pharmacology (2024) Vol. 64, Iss. 7, pp. 828-839
Open Access | Times Cited: 6
Mark J. Ellison, Emily Hutton, Lynn R. Webster, et al.
The Journal of Clinical Pharmacology (2024) Vol. 64, Iss. 7, pp. 828-839
Open Access | Times Cited: 6
Showing 6 citing articles:
Comparison of intranasal naloxone and intranasal nalmefene in a translational model assessing the impact of synthetic opioid overdose on respiratory depression and cardiac arrest
Céline M. Laffont, Prasad Purohit, Nash Delcamp, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Céline M. Laffont, Prasad Purohit, Nash Delcamp, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Synthetic opioids have disrupted conventional wisdom for treating opioid overdose.
Phil Skolnick, Jordan Paavola, Christian Heidbreder
Drug and Alcohol Dependence Reports (2024) Vol. 12, pp. 100268-100268
Open Access | Times Cited: 2
Phil Skolnick, Jordan Paavola, Christian Heidbreder
Drug and Alcohol Dependence Reports (2024) Vol. 12, pp. 100268-100268
Open Access | Times Cited: 2
Comment on: Can Intranasal Nalmefene Reduce the Number of Opioid Overdose Deaths?
Phil Skolnick
Clinical Pharmacology in Drug Development (2024) Vol. 13, Iss. 3, pp. 317-318
Open Access | Times Cited: 1
Phil Skolnick
Clinical Pharmacology in Drug Development (2024) Vol. 13, Iss. 3, pp. 317-318
Open Access | Times Cited: 1
Groundbreaking Research from NIDA Addressing the Challenges of the Opioid Epidemic
Nora D. Volkow, Leslie R. Dye
Journal of Medical Toxicology (2024)
Open Access | Times Cited: 1
Nora D. Volkow, Leslie R. Dye
Journal of Medical Toxicology (2024)
Open Access | Times Cited: 1
Methocinnamox is a Potent and Long-Acting Antagonist that can Prevent and Reverse Opioid-Induced Respiratory Depression
James A. Carr, Daniel J Morgan
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 1, pp. 1-3
Closed Access
James A. Carr, Daniel J Morgan
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 1, pp. 1-3
Closed Access
Time Course of Reversal of Fentanyl‐Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene and Intramuscular and Intranasal Naloxone
Alessandra Cipriano, Glen Apseloff, Ram P. Kapil, et al.
The Journal of Clinical Pharmacology (2024)
Open Access
Alessandra Cipriano, Glen Apseloff, Ram P. Kapil, et al.
The Journal of Clinical Pharmacology (2024)
Open Access